ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

FIBRINOGEN

Active substance (INN) · ATC B02BC30 · 1 products authorised in Romania
◀ Back
1

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

CodeProtocolStatusRoleSublistGP
A16AA07 METRELEPTINUM In force mentioned in the text C1-G22 NO
B014I SULODEXIDUM(original și biosimilar) In force mentioned in the text B YES
L014C RITUXIMABUM (original si biosimilar) In force mentioned in the text C2-P3 NO
L01XC17 NIVOLUMABUM In force mentioned in the text C2-P3 NO
L01XX24 PEGASPARGASUM In force mentioned in the text C2-P3 NO
L01XX71 TISAGENLECLEUCEL In force mentioned in the text C2-P3 NO
M09AX09 ONASEMNOGEN ABEPARVOVEC In force mentioned in the text C2-P6.24 NO
M09AX10 RISDIPLAMUM In force mentioned in the text C2-P6.24 NO
2

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand nameFormStrengthHolderATCRx
TACHOSILMATRICE PENTRU HEMOSTAZA LOCALA5,5 mg/ 2,0 U.I.CORZA MEDICAL GMBH - GERMANIAB02BC30PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.